156 related articles for article (PubMed ID: 6146342)
21. Beta-adrenergic blockade affects initial drug distribution due to decreased cardiac output and altered blood flow distribution.
Avram MJ; Krejcie TC; Henthorn TK; Niemann CU
J Pharmacol Exp Ther; 2004 Nov; 311(2):617-24. PubMed ID: 15197245
[TBL] [Abstract][Full Text] [Related]
22. Influence of rifampicin, phenobarbital and cimetidine on mixed function monooxygenase in extensive and poor metabolizers of debrisoquine.
Leclercq V; Desager JP; Horsmans Y; Van Nieuwenhuyze Y; Harvengt C
Int J Clin Pharmacol Ther Toxicol; 1989 Dec; 27(12):593-8. PubMed ID: 2613393
[TBL] [Abstract][Full Text] [Related]
23. Effects of chlorpromazine on the disposition and beta-adrenergic blocking activity of propranolol in the dog.
Bai SA; Abramson FP
J Pharmacokinet Biopharm; 1984 Jun; 12(3):333-49. PubMed ID: 6502474
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic drug interactions with theophylline.
Jonkman JH; Upton RA
Clin Pharmacokinet; 1984; 9(4):309-34. PubMed ID: 6147220
[TBL] [Abstract][Full Text] [Related]
25. Impaired enzyme induction by rifampicin in the elderly.
Twum-Barima Y; Finnigan T; Habash AI; Cape RD; Carruthers SG
Br J Clin Pharmacol; 1984 May; 17(5):595-7. PubMed ID: 6733008
[No Abstract] [Full Text] [Related]
26. Influence of smoking and age on pharmacokinetics of beta-receptor blockers.
Hitzenberger G; Fitscha P; Beveridge T; Nüesch E; Pacha W
Gerontology; 1982; 28 Suppl 1():93-100. PubMed ID: 6123470
[TBL] [Abstract][Full Text] [Related]
27. Divergent effects of different enzyme-inducing agents on endogenous and exogenous testosterone.
Bammel A; van der Mee K; Ohnhaus EE; Kirch W
Eur J Clin Pharmacol; 1992; 42(6):641-4. PubMed ID: 1623905
[TBL] [Abstract][Full Text] [Related]
28. Enzyme induction by phenobarbitone and vitamin K1 disposition in man.
Park BK; Wilson AC; Kaatz G; Ohnhaus EE
Br J Clin Pharmacol; 1984 Jul; 18(1):94-7. PubMed ID: 6743493
[TBL] [Abstract][Full Text] [Related]
29. Comparative investigations of the enzyme-inducing activity of rifampicin and barbiturates in man.
Nitti V; Ninni A; Meola G; Iuliano A; Curci G
Chemotherapy; 1973 Oct; 19(4):206-10. PubMed ID: 4772960
[No Abstract] [Full Text] [Related]
30. The polymorphic oxidation of beta-adrenoceptor antagonists. Clinical pharmacokinetic considerations.
Lennard MS; Tucker GT; Woods HF
Clin Pharmacokinet; 1986; 11(1):1-17. PubMed ID: 2868819
[TBL] [Abstract][Full Text] [Related]
31. Effect of rifampicin on metoprolol and antipyrine kinetics.
Bennett PN; John VA; Whitmarsh VB
Br J Clin Pharmacol; 1982 Mar; 13(3):387-91. PubMed ID: 7059439
[TBL] [Abstract][Full Text] [Related]
32. The effect of six beta-adrenolytics and labetalol on hepatic biotransformation studied by antipyrine test, in man.
Adamska-Dyniewska H; Dziekański S; Pruszczyński J
Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):303-7. PubMed ID: 2874117
[TBL] [Abstract][Full Text] [Related]
33. Effect of enzyme induction on plasma lipids using antipyrine, phenobarbital, and rifampicin.
Ohnhaus EE; Kirchhof B; Peheim E
Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):591-7. PubMed ID: 35298
[No Abstract] [Full Text] [Related]
34. A link between liver microsomal enzyme activity and thyroid hormone metabolism in man.
Ohnhaus EE; Studer H
Br J Clin Pharmacol; 1983 Jan; 15(1):71-6. PubMed ID: 6849748
[TBL] [Abstract][Full Text] [Related]
35. A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects.
Rigby JW; Scott AK; Hawksworth GM; Petrie JC
Br J Clin Pharmacol; 1985 Oct; 20(4):327-31. PubMed ID: 2866783
[TBL] [Abstract][Full Text] [Related]
36. Clinical implications of enzyme induction and enzyme inhibition.
Park BK; Breckenridge AM
Clin Pharmacokinet; 1981; 6(1):1-24. PubMed ID: 6113907
[TBL] [Abstract][Full Text] [Related]
37. [Comparative pharmacokinetics of beta-blockers].
Kiechel JR; Meier J
Nouv Presse Med; 1978 Sep; 7(31):2685-7. PubMed ID: 30943
[No Abstract] [Full Text] [Related]
38. Effect of butalbital and phenobarbital pretreatment on antipyrine clearance in the rat.
Tse FL; Chang T; Jaffe JM
Arch Int Pharmacodyn Ther; 1986 Feb; 279(2):181-94. PubMed ID: 3963935
[TBL] [Abstract][Full Text] [Related]
39. Effects of drug pretreatment on antipyrine levels in blood and tissues: an example of multiple drug interactions.
Sotaniemi EA
Pharmacology; 1973; 10(5):306-16. PubMed ID: 4764537
[No Abstract] [Full Text] [Related]
40. Research on the eventual enzymatic induction activity of cetiedil in rat and man.
Larousse C; Kergueris MF; Le Normand Y; Visset J
Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):195-9. PubMed ID: 7390670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
